United States (US) Non-steroidal Anti-inflammatory Drugs Market (2025-2031) | Value, Outlook, Share, Segmentation, Growth, Size & Revenue, Analysis, Industry, Forecast, Competitive Landscape, Companies, Trends

Market Forecast By Route of Administration (Oral, Parenteral, Topical), By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Competitive Landscape
Product Code: ETC9971649 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Non-steroidal Anti-inflammatory Drugs Market Outlook
  • Market Size of United States (US) Non-steroidal Anti-inflammatory Drugs Market, 2024
  • Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market, 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Revenues & Volume for the Period 2021- 2031
  • United States (US) Non-steroidal Anti-inflammatory Drugs Market Trend Evolution
  • United States (US) Non-steroidal Anti-inflammatory Drugs Market Drivers and Challenges
  • United States (US) Non-steroidal Anti-inflammatory Drugs Price Trends
  • United States (US) Non-steroidal Anti-inflammatory Drugs Porter's Five Forces
  • United States (US) Non-steroidal Anti-inflammatory Drugs Industry Life Cycle
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Topical for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Disease Indication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Arthritis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Migraine for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Ophthalmic Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • United States (US) Non-steroidal Anti-inflammatory Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Disease Indication
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Non-steroidal Anti-inflammatory Drugs Top Companies Market Share
  • United States (US) Non-steroidal Anti-inflammatory Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Non-steroidal Anti-inflammatory Drugs Company Profiles
  • United States (US) Non-steroidal Anti-inflammatory Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Non-steroidal Anti-inflammatory Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Non-steroidal Anti-inflammatory Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle

3.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces

3.5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.6 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases such as arthritis and musculoskeletal disorders

4.2.2 Growing geriatric population in the United States

4.2.3 Rising awareness about the benefits of non-steroidal anti-inflammatory drugs (NSAIDs) for pain management

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval and marketing

4.3.2 Potential side effects associated with long-term use of NSAIDs

4.3.3 Presence of alternative therapies and treatments for pain management

5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Trends

6 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Types

6.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration

6.1.1 Overview and Analysis

6.1.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2021- 2031F

6.1.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.1.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F

6.1.5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2021- 2031F

6.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2021- 2031F

6.2.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2021- 2031F

6.2.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2021- 2031F

6.2.5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.3.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 United States (US) Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics

7.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries

7.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries

8 United States (US) Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators

8.1 Number of prescriptions for NSAIDs issued by healthcare providers

8.2 Patient adherence rates to NSAID treatment regimens

8.3 Frequency of recommendations for NSAIDs in clinical practice

9 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment

9.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape

10.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All